LFCR
Price
$4.86
Change
-$0.19 (-3.76%)
Updated
Jul 7 closing price
Capitalization
182.3M
23 days until earnings call
Intraday BUY SELL Signals
PRFX
Price
$1.34
Change
-$0.05 (-3.60%)
Updated
Jul 7 closing price
Capitalization
4.05M
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LFCR vs PRFX

LFCR vs PRFX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
LFCR vs. PRFX commentary
Jul 08, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LFCR is a Hold and PRFX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 08, 2026
Stock price -- (LFCR: $5.05 vs. PRFX: $1.39)
Brand notoriety: LFCR and PRFX are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: LFCR: 50% vs. PRFX: 1%
Market capitalization -- LFCR: $182.3M vs. PRFX: $4.05M
LFCR [@Pharmaceuticals: Generic] is valued at $182.3M. PRFX’s [@Pharmaceuticals: Generic] market capitalization is $4.05M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $63.66B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.14B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LFCR’s FA Score shows that 1 FA rating(s) are green whilePRFX’s FA Score has 1 green FA rating(s).

  • LFCR’s FA Score: 1 green, 4 red.
  • PRFX’s FA Score: 1 green, 4 red.
According to our system of comparison, LFCR is a better buy in the long-term than PRFX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LFCR’s TA Score shows that 4 TA indicator(s) are bullish while PRFX’s TA Score has 0 bullish TA indicator(s).

  • LFCR’s TA Score: 4 bullish, 5 bearish.
  • PRFX’s TA Score: 0 bullish, 5 bearish.
According to our system of comparison, LFCR is a better buy in the short-term than PRFX.

Price Growth

LFCR (@Pharmaceuticals: Generic) experienced а -3.81% price change this week, while PRFX (@Pharmaceuticals: Generic) price change was +0.72% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.57%. For the same industry, the average monthly price growth was +6.69%, and the average quarterly price growth was +19.27%.

Reported Earning Dates

LFCR is expected to report earnings on Jul 31, 2026.

PRFX is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.57% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LFCR($182M) has a higher market cap than PRFX($4.05M). LFCR has higher P/E ratio than PRFX: LFCR (51.23) vs PRFX (0.02). LFCR YTD gains are higher at: -38.264 vs. PRFX (-56.684). PRFX has higher annual earnings (EBITDA): -3.94M vs. LFCR (-8.81M). PRFX has less debt than LFCR: PRFX (56K) vs LFCR (149M). LFCR has higher revenues than PRFX: LFCR (129M) vs PRFX (0).
LFCRPRFXLFCR / PRFX
Capitalization182M4.05M4,498%
EBITDA-8.81M-3.94M224%
Gain YTD-38.264-56.68468%
P/E Ratio51.230.02315,189%
Revenue129M0-
Total Cash20.8MN/A-
Total Debt149M56K266,071%
FUNDAMENTALS RATINGS
LFCR vs PRFX: Fundamental Ratings
LFCR
PRFX
OUTLOOK RATING
1..100
5898
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
24
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
6290
P/E GROWTH RATING
1..100
697
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRFX's Valuation (24) in the null industry is somewhat better than the same rating for LFCR (88) in the Industrial Specialties industry. This means that PRFX’s stock grew somewhat faster than LFCR’s over the last 12 months.

PRFX's Profit vs Risk Rating (100) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that PRFX’s stock grew similarly to LFCR’s over the last 12 months.

PRFX's SMR Rating (99) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that PRFX’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's Price Growth Rating (62) in the Industrial Specialties industry is in the same range as PRFX (90) in the null industry. This means that LFCR’s stock grew similarly to PRFX’s over the last 12 months.

LFCR's P/E Growth Rating (6) in the Industrial Specialties industry is significantly better than the same rating for PRFX (97) in the null industry. This means that LFCR’s stock grew significantly faster than PRFX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
LFCRPRFX
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 7 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
N/A
Momentum
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
73%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 13 days ago
79%
Bearish Trend 15 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
LFCR
Daily Signal:
Gain/Loss:
PRFX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NTGR22.09N/A
N/A
NETGEAR
NVX0.46N/A
N/A
NOVONIX Limited
CCTG1.12N/A
N/A
CCSC Technology International Holdings Limited
USLM102.78N/A
N/A
United States Lime & Minerals
MAS79.34-1.70
-2.10%
Masco Corp

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
N/A
SHPH - LFCR
31%
Poorly correlated
N/A
COLL - LFCR
28%
Poorly correlated
N/A
PAHC - LFCR
27%
Poorly correlated
N/A
TLRY - LFCR
27%
Poorly correlated
N/A
VTRS - LFCR
25%
Poorly correlated
N/A
More

PRFX and

Correlation & Price change

A.I.dvisor tells us that PRFX and INCR have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PRFX and INCR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRFX
1D Price
Change %
PRFX100%
N/A
INCR - PRFX
24%
Poorly correlated
N/A
AMRX - PRFX
24%
Poorly correlated
N/A
LFCR - PRFX
21%
Poorly correlated
N/A
KMDA - PRFX
21%
Poorly correlated
N/A
SUPN - PRFX
21%
Poorly correlated
N/A
More